Platform
Features
0 followers
TOLREMO therapeutics is a developer of small molecules intended to target novel drug resistance pathways in cancer therapy.
Industries
Headquarters
Employees
Links
Stefanie Flückiger-Mangual
Roche
221 followers
Lonza
27 followers
Debiopharm
1 follower
SHL Medical
2 followers
AbbVie
152 followers
Siegfried Holding
Grifols
19 followers
Incyte
14 followers
Recursion Pharmaceuticals
6 followers
Amgen
181 followers
PTC Therapeutics
8 followers
Discover companies